Lilotomab

• CAT Number: I041586
• CAS Number: 1453362-55-4
• Purity: ≥95%

Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity[1].
Lilotomab (0-40 µg/mL; 12 days) reduces the clonogenic survival of DOHH2 and Ramos cells[1].
Lilotomab (40 µg/mL; 18 h) induces slight apoptosis in DOHH2 cells[1].
Lilotomab (0.5 mg/kg; i.v.; once) inhibits tumor growth in mice[1].

Reference

[1]. Malenge MM, et al. 177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma. J Nucl Med. 2020 Oct;61(10):1468-1475.
 [Content Brief]